Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Virus Diseases × Cantharidin × Clear all

Sponsor

Conditions

Warts 1 Virus Diseases 1 Skin Diseases, Viral 1 Skin Diseases, Infectious 1 Skin Diseases 1 Sexually Transmitted Diseases, Viral 1 Sexually Transmitted Diseases 1 Papillomavirus Infections 1 Condylomata Acuminata 1

Interventions

ledipasvir, sofosbuvir drug combination 1 VP-102 1 Therapies, Investigational 1 Imiquimod 1 Gels 1 Cantharidin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03981822 2024-11-27

CARE-1

Verrica Pharmaceuticals Inc.

Phase 2 Completed

105 enrolled 24 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Skin Diseases, Skin Diseases, Infectious, Virus Diseases, Warts, Sexually Transmitted Diseases, Viral, Skin Diseases, Viral, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡